DRUG STUDY

GENERIC NAME: TRAMADOL Route of Administration: DRUG CLASS Therape utic Class: analgesic s (centrally acting) MODE OF ACTION
Chemical Effect: Binds to mu-opiod receptors. Inhibits reuptake of serotonin and norepineph rine in the CNS. Therapeut ic effect: Decreased pain

Dosage: 50 mg ADVERSE REACTIONS TO WATCH FOR DRUG INTERACTIONS Decreased effectiveness with carbamazepi ne Increased risk of tramadol to xicity with MAOIs

BRAND NAME: Available Stock: NURSING CONSIDERATIONS Assess bowel function routinely. Minimize constipation. Assess previous analgesic history. Tramadol is not recommended for opiod dependent patients (withdrawal symptoms) Monitor patients for seizures. HEALTH TEACHINGS Instruct the patient on how and when to ask for pain medication. Caution to avoid activities requiring alertness until response to medication is unknown.

INIDCATIONS/ CONTRA INDICATIONS

I: moderate Sedation, to moderately dizziness/vertigo, severe pain headache, confusion, C/I: pregnancy; allergy to tramadol; acute intoxication with alcohol, opioi ds, psychotropic drugs or other centrally acting analgesics; lactation. Use cautiously with seizures, concomitant
dreaming, anxiety, seizures, Hypotension, tachycardia, bradycardia , Sweating,pruritus, rash, pallor, urticaria, Nausea, vomiting, dry mouth, constipation, flatulence Potential for abuse, anaphylactoid r eactions

Caution to avoid May cause alcohol or serum creatinine, other CNS elevated liver depressants enzymes, decreased Encourage hemoglobin and patient to

use of CNS depressants or MAOIs, renal or hepatic impairment.

proteinuria. Overdose/ toxicity may cause respiratory depression. Naloxone (Narcan) may reverse it.

turn, cough, breathe deeply every 2 hr to prevent atelectasis.